To cause bone loss, the AIN-93G diet was provided to three-month-old female SpragueDawley rats with ovariectomies and a sham operation for seven weeks
Daily consistency is non-negotiable for clinical-grade results
The timeline is shown in Fig
Treatment of B6 mice with the GLS1 inhibitor BPTES significantly reduced histological scores in the spinal cord of affected animals, lowered the number of CD4 + T cells, IL-17A and IFN-producing CD4 + T cells in the spinal cord, substantially decreased clinical scores and weight loss, and ameliorated experimental autoimmune encephalomyelitis ( + CD4 - CD8 - cells), the urinary albumin/creatinine ratio, glomerular nephropathy score, and T-cell infiltration with IL-17A in the kidneys, relieving the EAE disease activity ( + T cells by inhibiting GLS1, glycolysis, and CD4 + T-cell differentiation in vitro by reducing the level of HIF1 protein, a key metabolic sensor in Th17 cells ( Table 1 )
N-acetylcysteine (NAC) : A precursor to glutathione, NAC can enhance levels when taken alongside IV therapy
The impaired mitochondrial function may lead to an abnormal increase in ROS production while the cellular capacity to eliminate ROS diminishes, significantly increasing intracellular oxidative stress levels (Zhao et al., 2022)
